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ABSTRACT
Objectives: We studied vendor perspectives about
potentially transferable lessons for implementing
organisations and national strategies surrounding the
procurement of Computerised Physician Order Entry
(CPOE)/Clinical Decision Support (CDS) systems in
English hospitals.
Setting: Data were collected from digitally audio-
recorded discussions from a series of CPOE/CDS
vendor round-table discussions held in September
2014 in the UK.
Participants: Nine participants, representing 6 key
vendors operating in the UK, attended. The discussions
were transcribed verbatim and thematically analysed.
Results: Vendors reported a range of challenges
surrounding the procurement and contracting
processes of CPOE/CDS systems, including hospitals’
inability to adequately assess their own needs and then
select a suitable product, rushed procurement and
implementation processes that resulted in difficulties in
meaningfully engaging with vendors, as well as
challenges relating to contracting leading to
ambiguities in implementation roles. Consequently,
relationships between system vendors and hospitals
were often strained, the vendors attributing this to a
lack of hospital management’s appreciation of the
complexities associated with implementation efforts.
Future anticipated challenges included issues
surrounding the standardisation of data to enable their
aggregation across systems for effective secondary
uses, and implementation of data exchange with
providers outside the hospital.
Conclusions: Our results indicate that there are
significant issues surrounding capacity to procure and
optimise CPOE/CDS systems among UK hospitals.
There is an urgent need to encourage more synergistic
and collaborative working between providers and
vendors and for a more centralised support for
National Health Service hospitals, which draws on a
wider body of experience, including a formalised
procurement framework with value-based product
specifications.
INTRODUCTION
Stimulated by monetary incentives, such as
the US Health Information Technology for
Economic and Clinical Health (HITECH)
Act and the English Integrated Digital Care
Technology Fund, the implementation of
medication-related Health Information
Technologies (HIT) in hospitals has resulted
in a recent surge of activity.1–4 The under-
lying hope is that such systems will contribute
to enhancing the efﬁciency, safety and
quality of healthcare.5–8
In the UK, such systems are commonly
referred to as electronic prescribing (or
ePrescribing) systems and are associated with
functionality surrounding prescribing, deci-
sion support at the point of care, transmis-
sion of prescribing-related information (eg,
when ordering or monitoring), medicines
administration, and use of data for secondary
uses (eg, quality improvement).9 In the USA,
commonly associated functionalities include
Computerised Physician Order Entry
(CPOE) systems that allow ordering of
Strengths and limitations of this study
▪ The vendor perspective provides a unique
insight into cross-organisational implementation
challenges.
▪ We have identified important organisational
drivers that can ‘make or break’ the implementa-
tion journey, long before a formal contract is
signed.
▪ We facilitated an in-depth and open discussion,
collecting and analysing the data applying rigor-
ous qualitative methods.
▪ However, we studied only eight vendors in the
English market, and the data collection period
was relatively short.
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medications tailored to individual patients, and linked
Clinical Decision Support (CDS) systems that provide
medication-related decision support.
In 2014, approximately 35% of English hospitals had
begun implementation of CDS functionality in at least one
ward or hospital department, while this ﬁgure was over 60%
for US hospitals.10 11 In England, the previous centralised
procurement model for HIT—the National Programme for
Information Technology (NPfIT)—has now been replaced
by localised decision-making by providers in system choice,
in the hope that this will promote local ownership of
decision-making and catalyse adoption efforts.12 13 There
are important lessons the international community can
learn from this change in strategic direction, as degrees of
political guidance in HIT implementation are deliberated
internationally. For example, the USA has adopted a model
where hospitals are encouraged to implement accredited
technologies stimulated by ﬁnancial incentives.4 However,
there are increasing concerns surrounding the governance
structures of this approach including the lack of formal
evaluation and ﬂexibility, as well as usability and interoper-
ability issues of technologies.14
Moreover, early implementing organisations tend to be
trailblazers and in many ways may not be representative of
the wider hospital community.5 15 16 There is therefore a
need to build more generalisable knowledge that later
implementers can draw on in order to make this journey as
smooth as possible. Vendors are a surprisingly underused
resource in this respect, although they have an important
complementary perspective to that of other stakeholders.
While organisational circumstances differ and implementa-
tion experience often remains localised, vendors tend to
accumulate implementation expertise by moving through
a variety of settings and contexts.17 18 Their knowledge and
experience therefore has the potential to offer important
insights into transferable lessons across organisational
boundaries. In the English context, some vendors have also
gained valuable strategic experiences from operating in the
changing political landscape.19
The ﬁndings reported here explore vendor perspectives
surrounding the procurement of CPOE/CDS systems in
hospitals in England. In doing so, we build on a substantial
body of previous work in primary care and hospital settings,
and an ongoing national evaluation of hospital CPOE/CDS
systems within the National Health Service
(NHS).3 5 9 13 17 19–28 We present the results from a series of
round-table discussions with vendors that aimed to explore
challenges surrounding the procurement of systems, and
associated strategies to address these. Our primary research
question was: What are the challenges surrounding the pro-
curement of hospital CPOE/CDS systems from the
vendors’ perspective and how could these be addressed?
MATERIALS AND METHODS
Institutional review board approval
The London City and East Research Ethics Committee
classed this work as a service evaluation. Participants
were provided with an information sheet offering an
overview of the aims of the study and a consent form to
be signed prior to the start of the event. The informa-
tion sheet and consent form described the aims of the
study and of how the data would be generated,
managed, analysed and used. All participants gave
written informed consent to take part.
Design
This qualitative focus group study was designed to
capture the vendors’ perspective on issues, challenges
and opportunities arising across the entire system’s life
cycle from the very early stages at which a hospital plans
the introduction of a CPOE/CDS system, right through
to the longer term optimisation and integration of the
system (box 1). The focus group design was chosen in
order to allow exchange of different implementation
experiences across systems and contexts.29 30
Participants
Building on previous work,25 a list of 17 key vendors cur-
rently actively operating (deﬁned as either having imple-
mented a relevant system or being in active discussions
with hospitals planning to implement) in the UK market
was drawn up. This shortlist of vendors was then
reviewed to include vendors who had either implemen-
ted systems in the UK context or in international con-
texts, excluding vendors who were selling newly
developed systems and had no procurement and imple-
mentation experience.
Box 1 Summary of themes and subthemes identified
▸ Limited organisational capabilities in the National Health
Service to select, procure and implement systems
– Resources and skills
– Developing and retaining internal capacity to implement
– Senior back-up and drive for implementations
– Rushed implementation timelines
– Understanding current and future processes
▸ The challenge of procuring a product that suits organisational
needs rather than wants
– Differentiating between organisational “wants” and “needs”
– Assessing vendors now and in the future
– The need for value-based product specifications
– Streamlining procurement and contracting processes
▸ Contracting as the creation of a formal partnership between
hospitals and vendors
– Building relationships with vendors before implementation
– Dialogue between vendors and customers
– Conflict resolution and dealing with delays
– Degree of vendor involvement
▸ Optimising systems and deriving value
– Standardisation
– Secondary uses of data
– Continuing to put the right infrastructure into place
– Integrating and sharing
– Competitive markets and continuing innovation
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This resulted in representatives from 10 organisations
being contacted via email and invited to take part.
Where possible, contact was made directly with indivi-
duals within the organisations whose expertise and
knowledge would ensure senior strategic insights could
be shared at the event. Where such individuals could
not easily be identiﬁed or were not available, other suit-
able representatives were identiﬁed by the vendor.
Of the 10 vendors targeted, 8 accepted the invitation
of which 6 were represented in the round-table discus-
sions. Of the remaining two vendors from the shortlist,
one did not respond to the invitation and another
declined to participate. It was agreed that up to a
maximum of two representatives from each vendor
could attend since relevant expertise and knowledge was
in some cases shared across multiple roles within the
vendor organisations. As a result, a total of nine partici-
pants took part.
Setting
The event took place in Birmingham, UK in September
2014.20 Of the nine delegates taking part, eight were phys-
ically present for the event and one joined the round-table
discussion from the USA via teleconferencing.
Data collection and handling
Three areas of interest which reﬂected the key stages in
the implementation and adoption journey undertaken
by vendors as well as their vision for the future formed
the basis for the discussions (see box 2). These were
held as three separate sessions lasting between 60 and
90 min each—one in the morning, and two in the after-
noon with either a lunch or coffee break between each.
While no data were collected during the breaks, this free
time provided participants with the opportunity for
further informal deliberation and may have impacted on
some of the subsequent discussions.
Sessions were moderated by two members of the
research team (ASl and JC). The moderators brieﬂy
introduced each topic and provided broad open-ended
questions to help initiate discussions. Where possible,
moderators sought to let participants guide discussions
themselves to ensure that data collected were not con-
strained by the expectations of the research team.
The audio-recordings were uploaded to a secure
server at the University of Edinburgh, and subsequently
transcribed by the research team’s senior secretary
(Rosemary Porteous). The anonymised transcripts were
then checked by a member of the research team present
at the event (LL).
Data analysis
We used the qualitative data analysis software package
NVivo V.10 for organising the data. The transcripts were
uploaded and initially coded along the three topic areas
(see box 2) by KMC, an experienced qualitative
researcher. We then inductively analysed the categories
for recurring themes based on frequency and salience
(or agreement among participants), in discussion with
LL.29 30 After initial analysis, emerging themes and sub-
themes were reﬁned through discussion within the
research team, consisting of experienced social scientists,
clinicians and medical informaticists. This discussion was
structured around the three main emerging themes sur-
rounding organisational capabilities, procurement and
contracting challenges, and system optimisation. It
resulted in reﬁnement of subcategories, with individual
team members helping to explore clinical and social
implications and challenges outlined by participants in
more detail.
We continued analysis until we achieved thematic sat-
uration,31 the point at which emerging themes were
repeatedly identiﬁed and no new themes were emerging.
To facilitate analysis, we drew on an analytical frame-
work based on ongoing work,28 which depicts the life
cycle of technology implementation within healthcare
organisations, from conception through implementation
towards optimisation. The model consists of the follow-
ing iterative stages: conceptualisation, project initiation,
functional speciﬁcation, drafting a business case,
procurement/tendering, system choice, contracting,
preimplementation planning, implementation and
optimisation. Conceptualising procurement with this
model helped to contextualise ﬁndings within the larger
implementation journey, as the stages are intimately
related and can impact on one another.
RESULTS
We drew on data from a total of nine participants and
analysed three audio-recorded round-table discussions
lasting a total of 4.5 h (table 1).
The following overarching themes were identiﬁed (see
box 1 for subthemes):
▸ Limited organisational capabilities in the NHS to
select, procure and implement systems;
▸ The challenge of procuring a product that suits
organisational needs rather than wants;
▸ Contracting as the creation of a formal partnership
between hospitals and vendors;
▸ Optimising systems and deriving value.
These themes will be examined in detail below.
Box 2 Key topics discussed
Topic 1: From conceptualisation to implementation
Key challenges and opportunities for vendors from the early
stages of project initiation through to implementation
Topic 2: Go-live and system stabilisation
Vendors’ experiences of going live with the system and what
lessons can be drawn from roll-outs to date
Topic 3: System optimisation, longer term integration, upgrades
and building a vision for the future
Issues relating to short-term and medium-term optimisation, and
discussion of the longer term vision and the planning required to
ensure service continuity, flexibility and scalability
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Limited organisational capabilities in the NHS to select,
procure and implement systems
Participants had worked with a number of hospitals
and were in broad agreement that, from their experi-
ence, there was a lack of resources to support the
appropriate and effective selection, procurement and
implementation of CDS/CPOE systems in NHS hospi-
tals. In this context, skills shortages in hospitals where
systems were deployed were particularly frequently men-
tioned, including limited expertise in business change,
benchmarking, product testing, contracting, project
management and service improvement. In line with
this, the stafﬁng of the implementation teams in
hospitals was viewed as inadequate in many cases, with
hospital teams lacking the right multidisciplinary
combination of knowledge surrounding clinical pro-
cesses, project management and software delivery
processes.
You’re buying a software product […] and therefore you
need to understand how software is made, released,
tested, accepted and all those things that we know as a
software company we do. And if the project manager has
no understanding of those sequences, especially where
they […] are releasing new functionality […] almost
quarterly, that all has to be factored in. Participant 8,
Vendor E
However, it was explained that organisations needed
to develop internal capacity to implement systems, as
well as to retain skilled staff. Vendors observed that
many hospitals employed external consultants on short-
term contracts as project managers, but these individuals
tended to lack inside organisational knowledge and took
their skills with them when they left.
We’re getting people coming from outside organisa-
tions…but you haven’t got a clue about what the organ-
isation is like and you spend six months learning what
the organisation is doing today. Never mind what it
needs to do tomorrow. And I think that’s part of the
problem…you need to be growing that expertise
in-house as part of your work… Participant 1, Vendor A
In addition, senior commitment from lead physicians
and/or chief executives to support implementation
efforts was often lacking and this hampered progress as
decisions were not made and visions of future states
were not effectively communicated organisation-wide.
In terms of monetary resources, the current ﬁnancial
payment proﬁle and milestone structure in the NHS
were viewed as being governed by an outcome-based
funding principle, where project milestones were seen
to be determined by availability (or lack) of money. For
example, vendors were paid for milestones such as
‘going-live’, as opposed to receiving reimbursement for
important strategic planning activities that preceded the
actual go-live event. As a result the focus shifted from
planning to outcomes, which was not always seen to be
beneﬁcial for implementations.
Just anything to do with when the money is coming into
the [hospital] needs to be decoupled from the broader
strategy. Because otherwise we get the perverse behavior
“everything needs to be done by this time because that’s
when we’re going to get the money […]”. We shouldn’t
have money for go-live; we shouldn’t be paid a lot of
money for me turning up on site because that’s a good
milestone… Participant 2, Vendor A
The impact of ﬁnancial resources on implementation
progress was also referred to on a national scale.
Table 1 Characteristics of participants and vendor organisations
Vendor Role and background Gender
Participant 1 A: international implementations,
established in the UK
Senior project manager M
Participant 2 A: international implementations,
established in the UK
Senior consultant with NHS nursing background M
Participant 3 B: international implementations, not
established in the UK
Senior manager with a background in sales and
marketing, has previously worked at vendor C
M
Participant 4 B: international implementations,
established in the UK
Product manager with healthcare IT specialist
background
M
Participant 5 C: international implementations,
established in the UK, integrated system
Consultant for medical process at with NHS
pharmacy background
F
Participant 6 C: international implementations,
established in the UK
Clinical strategist with nursing background M
Participant 7 D: international implementations,
established in the UK
Senior manager M
Participant 8 E: international implementations, not
established in the UK
Senior manager, formerly worked for Vendor C M
Participant 9 (via
teleconference)
F: international implementations, not
established in the UK
Senior manager leading international
implementations of systems
M
F, female; IT, information technology; M, male; NHS, National Health Service.
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Although the NHS’ Technology Fund was viewed to
stimulate the initial phases of implementations, it was
seen as limited in helping hospitals to resource further
roll-out and optimisation as it consisted of relatively
limited funding over a ﬁnite period of time.
As a result of ﬁnancially driven milestones, implemen-
tations were regularly seen as being rushed with hospi-
tals wanting to implement complex functionality too
early. Vendors, on the other hand, felt that implementa-
tion timelines needed to be more considered, begin-
ning with implementing relatively straightforward
functionality in less complex areas in order to help
organisations get used to the basic changes brought
about by the new system in relatively stable environ-
ments. The roll-out was then ideally governed by imple-
menting in areas that were somehow linked to each
other. In this context, the notion of a ‘pilot’ was viewed
as unhelpful for the implementation process as systems
were not, as in conventional pilot projects tested and
then modiﬁed, but implemented gradually throughout
the organisation.
I wouldn’t call it a pilot phase, for me this is about the
ﬁrst wards to go live, not pilot because pilot is like testing
something that might not actually be used and I like not
to use the word pilot. Participant 2, Vendor A
This strategy would also help hospitals to learn from
areas that went live ﬁrst. Incorporating these lessons was
seen as a crucial part of the implementation process,
although frequently overlooked.
They [hospitals] want to go live on the system with all the
bells and whistles there and then, which will therefore
risk future adoptions. Users are going to grab that paper
chart because they know how to use that paper chart
[…]. Whereas I think it’s much better from my experi-
ence to go-live with something which is relatively simple,
potentially replicates paper, so you roll out this advanced
functionality be it drug checking, adverse drug reaction
forms that kind of stuff after the initial adoption stage
has pitted out. Participant 5, Vendor C
A lack of considered in-depth planning was also
observed in relation to an often inadequate understand-
ing of current and future business and work processes.
As a result, managers in hospitals were unaware of the
way systems were actually used and existing processes
were modiﬁed to accommodate systems.
I’m always surprised to see the number of workarounds
that hospitals will put into place. And the actual project
management […] and the IT staff that we would work
directly with actually have no idea of what’s actually hap-
pening on the ward. And a lot of times that affects them
when they go through things like regular system updates
and things like that. They’re not testing their own pro-
cesses because they don’t understand their own pro-
cesses. Participant 9, Vendor F
Mapping of future processes and ensuring that these
were adhered to, was viewed as important, as this would
help to ensure that best practice guidelines would be fol-
lowed and systems would be used effectively.
Procuring a product that suits organisational needs rather
than wants
Procuring a product that suited and addressed organisa-
tional needs was seen by vendors as a key decision. A dis-
tinction needed to be made between what
organisational managers thought they needed (which was
often different from they actually needed) and what deci-
sion makers wanted.
Understanding the organisation’s need and procuring
a product based on this was also seen as the best way to
ensure that functionalities were effectively adopted. In
this context, it was reiterated that complex functional-
ities (which were often on wish lists of hospitals) were
not necessarily suitable for all organisations, particularly
if they were implemented too early on in the process.
What I want is everything that gets talked about up to the
point where you go live and you suddenly realise that you
don’t want all of these. What you need is this, and this is
the difference between giving everything that sparkles
and is bright on day one or just giving a system that
works on day one. Participant 2, Vendor A
Before formal procurement had started, when decid-
ing on a system, frequent contact with potential vendors
and other organisations that were further on in the
implementation journey was seen as helpful. Scripted
system demonstrations (where organisations determine
in advance what they want vendors to demonstrate) were
viewed of limited value, as these failed to take account
of and reﬂect providers organisational circumstances.
The need for a more comprehensive evaluation of
vendors during requirement evaluation was therefore
highlighted.
Scripted demos are the norm in most places and they
can actually end up in a bias. Having a proper business
case model, you should be going in assessing the suppli-
ers in some format that you can score, because otherwise
you end up with a mixed matrix of scores and you’ve got
to question how valid is that score at the end of the day.
Is it subjective or objective? Participant 7, Vendor D
As part of the assessment of vendors, an assessment
of future functionality was stated to be necessary in
order to determine the compatibility of the product
and the organisation. This was, however, viewed as
being complicated by the current immaturity of the
implementation landscape and existing systems.
Participants further argued that product speciﬁcations,
a common feature of procurements, were constraining
and often too granular to reﬂect realistic product assess-
ments. Although the notion of output-based speciﬁca-
tions (OBS) was welcomed over the use of functional
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speciﬁcations in helping to move away from technical
features towards process improvement; participants
argued that value-based outputs that allowed vendors to
understand reasons behind technological requests were
still lacking in current procurements.
I think one of the things that we need to be trailing
towards is value based statements. So why are you doing
it, why do you want the answer to this question? So it’s “I
want to do something because” and we don’t have that in
either functional specs [speciﬁcations] or OBS’ at the
moment… Participant 1, Vendor A
The issues outlined above could partly be addressed
by streamlining procurement and contracting processes,
as an overall framework for procurement was still
lacking. Participants recommended that this framework
should include an organisational readiness assessment
before procurement to ensure that necessary resources
and skills are available, and giving vendors time and
information about local organisational processes before
system demonstrations to make these more locally
relevant.
Contracting as the creation of a formal partnership
between hospitals and vendors
Vendors highlighted how building relationships with
hospitals well before implementation was important in
order to explore together what system would be best
suited to the needs of the organisation. Such relation-
ship building, although time-consuming for both sides,
could help hospitals to avoid purchasing systems that
were not suitable for them and help vendors understand
expectations. It was stated that this dialogue between
customers and vendors should ideally happen before
the tendering phase, as otherwise the discussion would
be commercially constrained.
Contracting was ideally viewed as the creation of a
formal partnership with hospitals. However, this was not
always the case, with many suggesting that the establish-
ment of formal contracts with the NHS felt more like a
risk transfer from hospitals to vendors, governed by
inﬂated expectations and penalisation for missing
deadlines.
The ideal contract is where you have a partnership, to
use that cliché, and that the contract sits on the shelf
and away you go with the implementation plan and the
thing goes forward. There’s a lack of appreciation some-
times as why, from a commercial point of view, that it
needs to be a balanced contract. Invariably it’s a risk
transfer completely to the commercial side; it’s not a risk
share… Participant 7, Vendor D
Delays on the hospital side were often felt to be due to
bureaucratic structures that hampered speedy decision-
making and competing demands on senior decision
makers’ time. This was not always seen as adequately
considered and documented, with many hospitals
‘blaming’ vendors for implementation delays.
If you have a clinical problem that needs to be solved by
a clinical advisory group or some other steering group,
because we need to make a deﬁnitive change or step
change in policy or procedure, that can take weeks and
weeks and weeks. Because that clinical advisory group or
drug and therapeutics team may not meet more than
every two months, so those kind of things cause delays.
Participant 2, Vendor A
Delays on the vendor side related mainly to processing
change requests for customisation, but the complexity of
these was often not sufﬁciently appreciated by the NHS
hospitals. Vendors noted that customisation was not
desired as it would make their product less generic and
therefore harder to implement across other sites.
Nevertheless, the speed at which requests were attended
to was governed by external demands such as regulatory
mandates, which meant that individual change requests
for customisation that were not crucial for patient safety
were often a low priority. Also, the potential impact of
change requests on different parts of the system meant
that they had to be subjected to lengthy testing
procedures.
So you do get some customers who say “oh can’t you not
just change this” and you get great problems in managing
client satisfaction when you say “yeah it might be
12 months from now before you get that unless it’s a clin-
ical safety issue”, which most of us tend to respond to
right away. Participant 7, Vendor D
It was generally felt that contracts were only referred
to when ‘things went wrong’ and vendors highlighted
that therefore important contractual components
included processes surrounding conﬂict resolution and
ways to deal with implementation delays. Contracts
further needed to include an outline of the involvement
of vendors during roll-out, but hospitals frequently
underestimated the change management assistance and
expertise vendors could offer. Although vendor support
was dependent on existing organisational structures,
needs and resources, it was seen to be frequently under-
estimated in most contracts.
Well they [hospitals] never ask for enough [support] in
my opinion. Never ask for enough. They completely
underestimate what value the supplier can bring to them.
And they always ask for it post-contract of course.
Participant 8, Vendor E
Optimising systems and deriving value
Secondary uses of data were seen as a major way to opti-
mise systems and derive value from the investments
made. However, it was acknowledged that in order to
achieve maximum returns for all stakeholders and
enable meaningful aggregation, data across systems
would need to be standardised.
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I think we’ve got a responsibility as suppliers to standard-
ise the data that we have amongst our clients. I kind of
think we’re not there yet speaking from our point of view
but it’s going towards that standardisation… Participant
5, Vendor C
Participants also highlighted that effectively drawing
on secondary uses of data would take time, particularly
in hospitals that were slow to adopt systems (as adoption
was a prerequisite for deriving value through secondary
uses of data). Continuing to put the right infrastructure
into place was therefore seen as an intermediate goal for
vendors in order to build a solid platform from which to
optimise uses in the future.
Integrating systems and sharing data across care set-
tings, particularly between general practitioners (GPs),
social care providers, pharmacies and hospitals, and with
patients was seen as another major future development.
It’s getting information back to GP systems. It means
getting electronic transfer of prescriptions sorted out to
local chemists. It means sharing information with social
carers so they can see what Mable has to have three times
a day and what the tablets look like […] That’s probably
the next big step in my mind… Participant 2, Vendor A
In order to achieve visions of an integrated healthcare
system and derive value through secondary uses of data,
vendors stressed the importance of competitive markets
and continuing innovation. But these were seen to be
heavily inﬂuenced by political decisions and funding
restrictions. England’s NPfIT12 13 was given as an
example where political decisions had stiﬂed healthy
commercial competition and inhibited effective team
working between vendors and hospitals through cen-
trally governed contracts.
I’d say the one big vision thing that we probably all agree
with is […] a continued, funded, vibrant, competitive
market place. Because the danger is health services can
do another National Programme. We’ll go into another
10 year hiatus and God knows what else. Participant 7,
Vendor D
Another potential inhibitor of progress was the com-
mercial capacity to deliver systems in a time of increasing
interest by hospitals and acceleration by the English
Technology Fund. As a result, vendors found themselves
‘cherry picking’ hospitals for implementation as they did
not have the capacity to deliver on all tenders.
DISCUSSION
We found that the CPOE/CDS vendor perspective pro-
vides important insights into cross-organisational imple-
mentation challenges. We identiﬁed important
organisational drivers that can ‘make or break’ the
implementation journey, long before any formal con-
tract is signed. Rushing of procurement processes can
result in a lack of appropriate appreciation of
organisational needs and meaningful engagement with
different vendors, resulting in acquisition of a product
ill-suited to the context of deployment. Once a contract
is signed, constructive dialogue between vendors and
customers can be inhibited by a lack of clarity surround-
ing implementation roles. Vendors represent a valuable
source of expertise that is often underappreciated by
hospitals implementing clinical information technology
(IT) systems. Important future challenges surrounding
system optimisation include standardisation of data so
that these can be aggregated across systems for meaning-
ful secondary uses, and implementation of data
exchange with organisations outside the hospital.
Our results indicate that a certain degree of centralisa-
tion of procurement and contracting processes may, in a
UK context, help to address the challenges identiﬁed.
We have summarised these in box 3. The need for a
more formalised procurement framework was frequently
highlighted by our participants, as currently English hos-
pitals appear to lack expertise in this area. It seems that
the ‘post-NPfIT autonomy’ surrounding procurement
has come at a price—while hospitals can now choose
software vendors, they ﬁnd it difﬁcult to do this in a con-
sidered way and there is a shortage of expertise and
experience in negotiating what are often very sizeable
contracts. Some form of federal support therefore
appears to be needed, but achieving a balance between
governmental assistance and perceived central control
will be difﬁcult.13 A potential strategy could take a shape
similar to the early stages of the Meaningful Use Criteria
in the USA,24 being based around value-based product
speciﬁcations, as suggested by our participants. The
English Department of Health’s National Information
Board framework has begun to tackle some of these
issues, including establishing a digital support service to
help organisations comply with national digital stan-
dards.32 This also considers the organisation’s digital
maturity. Here, it will be important to build on existing
commercial and procurement guidance to include
Box 3 Potential ways to address cross-organisational
procurement challenges through increased central
guidance
▸ Increasing standards surrounding procurement and contract-
ing processes (building on existing purchasing guidance
through centralised system accreditation and standards)
▸ More considered implementation timelines (locally and
nationally)
▸ A central resource helping the National Health Service to
develop skills to procure and implement systems effectively
▸ Guidance to support product choice through devising func-
tional, output-based, and value-based specifications
▸ Ensuring that commercial markets remain competitive and no
monopolies emerge to ensure continuing innovation
▸ Continued federal funding to support procurement, implemen-
tation, and optimisation
▸ Guidance surrounding the standardisation systems to allow
integration and sharing on larger scales in the future
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considerations surrounding interoperability to ensure
effective future exchange of information between orga-
nisations.33 As our work indicates, this can only be
achieved if some centralised procurement guidance sur-
rounding system accreditation exists, as individual orga-
nisations are likely to seek short-term value (while
setting up interoperable systems form the start tends to
be more costly in the short term). We have summarised
some strategies for organisations to consider in relation
to vendor and product selection in box 4.
In light of existing commercial sensitivities surrounding
contracts and procurement, and an associated under-
representation of vendor perspectives, this study has
helped to explore procurement-related insights and
potentially transferable lessons. However, this work also
has a number of limitations. We studied eight vendors,
resulting in a relatively small number of participants
representing a limited amount of (albeit key) organisa-
tions operating in the UK, and the data collection period
was relatively short. This may have resulted in potentially
limited transferability of ﬁndings. Nevertheless, we have
brought together high-level representatives from the key
CPOE/CDS system vendors in the English market, allow-
ing a very rich, interactive and open discussion (which
would have been difﬁcult with a greater number of parti-
cipants). By recording it and coding emerging concepts,
we were able to identify a number of what we believe are
important lessons, although these need to be interpreted
within the English context. For example, the dominance
of Epic in the North American market has been the
subject of recent discussions, with fears that one commer-
cial company will have a monopoly—a similar situation
already encountered in the English NPfIT.34 Participants
were acutely aware of the potential pitfalls of such a mon-
opoly, fearing that it can hinder commercial competition
and stiﬂe innovation.35 Most emerging themes were
common among participants, with no divergent opinions
on the main issues. There were, however, some minor dis-
agreements in relation to speciﬁcs, particularly regarding
the degree of standardisation of contracts between
healthcare organisations and vendors, the nature of
vendor involvement in actual implementation-related
activities, and the commercial capacity to deliver desired
functionality.
Some of our ﬁndings mirror existing evidence in rela-
tion to the signiﬁcance of senior management and phys-
ician buy-in to support implementations;36 37 adequate
ﬁnancial resources to ﬁnance and incentivise initia-
tives;38 39 and work process redesign to realise beneﬁts
associated with technologies.40–42 The signiﬁcant poten-
tial of secondary uses of data from systems has also been
previously highlighted. Our work adds important per-
spectives surrounding procurement and contracting pro-
cesses and how these need to suit individual
organisations while also ensuring that wider national
needs are met such as larger scale information exchange.
Such views may be missing in current managerial dis-
courses, as these are often focused on localised organisa-
tional change. Important areas in this context include
the creation of formal partnerships between hospitals
and vendors; and the optimisation of systems and the der-
ivation of data. Future work should examine these issues
in more detail, particularly in relation to a potential align-
ment of organisational and vendor priorities, and deter-
mine whether they have international relevance or reﬂect
England’s individual circumstances.
Our results also suggest that the UK healthcare sector
is lagging behind other industries in relation to forging
effective relationships with commercial vendors. It has
been argued that this is partly due to a disconnect
between the organisational purchasing department and
decision makers. Consequently, there tends to be a drive
to get the best deal at the lowest price resulting in a lack
of trust between vendors and hospitals. These strained
relationships need to be more effectively managed by
drawing on more sophisticated strategies from other
industries.43 Examples may include proactive approaches
that allow cooperative partnerships between hospitals
and vendors, as well as robust and more coordinated
procurement strategies (as discussed above) with asso-
ciated process evaluations.44 45
CONCLUSIONS
The experiences of procuring CPOE/CDS systems in
England’s NHS illustrate how the political environment
surrounding implementations can affect relationships
on the ground. As implementing organisations are now
required to procure their own systems, progress has
been hampered by limited organisational capacity to
select suitable products. More centralised procurement
support has the potential to be beneﬁcial, but the
balance between ‘too much’ and ‘too little’ government
involvement will be hard to achieve.
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